Adjuvant Vaccines Could Have Helped To Prevent H1N1 Shortfall, Industry Tells Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has yet to approve adjuvanted influenza vaccines when they have been in use in Europe since 1997.